Researchers at the Centre for Genomic Regulation (CRG) and Imperial College London have found a switch that regulates the activity of a gene that causes diabetes. The findings, published in Nature Cell Biology, highlight potential new vulnerabilities in the disease and could lead to the development of new therapeutic strategies.